• Clinical Trials - Alzheimer's disease (AD)

    Study Objective Contact
    A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-Finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects with Early Alzheimer's Disease [LCID Study Number: 2013-011] The purpose of this study is to determine if the study drug (BAN2401) is safe and effective in subjects with Mild Cognitive Impairment due to Alzheimer’s disease or mild Alzheimer’s disease Principal Investigator(s):
    Yuval Zabar, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Nicholas F. Ventura.
    Evaluating The Impact Of Cerebral Ischemic And Degenerative Changes On Cognition [LCID Study Number: 2008-029] The purpose of this research study is to evaluate whether or not cerebral atrophy scores and ischemia obtained from your brain MRI can correlate with your mini mental test results. Principal Investigator(s):
    Sami H. Erbay, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Kaan D. Erbay,
    Karen L. Hanley.